Loading your research…

Opening the latest published company and exchange records.

EarningsCanvas Company research, closer to the source.

Source health MembershipAll times IST

NSE · NSE SME · BSE

Live market announcements

Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.

3 / 3Exchange feeds checked

Other disclosuresNSE · ZYDUSLIFE

Zydus Lifesciences Limited

Press Release

Published 5 Oct 2026, 20:41 ISTOpen source filing

01 / The disclosure

What the company shared

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 05, 2026, titled "Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.".

Exchange-provided summary Company profile

A question for your research

Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.

The evidence

Read the source excerpts

Exchange listing available

PDF text extraction is queued. The summary above comes from the exchange listing.

Source & verificationView the disclosure trail

Summary method: Exchange-provided text; no generated financial figures
Exchange identifier: 106807525
First collected: 5 Oct 2026, 22:51 IST
PDF extraction: pending

Official exchange listing

You’ve reached the end of this disclosure.